nach oben

Current Treatment Options in Psychiatry

Erschienen in:

01.06.2019 | PTSD (S Creech and L Sippel, Section Editors)

Dealing with Complexity and Comorbidity: Opportunity for Transdiagnostic Treatment for PTSD

verfasst von: Cassidy A. Gutner, PhD, Candice Presseau, PhD

Erschienen in: Current Treatment Options in Psychiatry | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of review

This review synthesizes literature on transdiagnostic treatments for PTSD and trauma-related psychopathology over the last 3 years and discusses their application across diverse contexts.

Recent findings

Global and domestic studies suggest that a transdiagnostic approach has the potential to address many challenges providers encounter when treating traumatized populations. Existing research shows that transdiagnostic approaches (including the Unified Protocol, Common Elements Treatment Approach, and Modular Approach to Therapy for Children) are effective across low- and high-resourced settings, populations, and with comorbid mental health symptoms. Moreover, transdiagnostic approaches offer flexibility in treatment delivery, adaptability across contexts, and parsimonious training to treatment providers. They also provide a standalone alternative for unable or unwilling individuals to engage in traditional single diagnosis trauma-focused treatment, or those presenting with complex presentations that might otherwise require sequential courses of targeted interventions.

Summary

The promise of transdiagnostic treatment for trauma populations is strong. Research is needed to examine patient and therapist perceptions of these approaches for optimally addressing PTSD and related symptoms, the extent to which they offer comparable, or perhaps better, outcomes than existing single diagnosis PTSD treatments, and their sustainability over time. Considerations of adaptations to transdiagnostic treatment manuals across settings are also needed.

Institute of Medicine. Treatment of posttraumatic stress disorder: an assessment of the evidence. Washington, DC: National Academies Press; 2007.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: Author; 2013.CrossRef

• Veterans Adminstration/Department of Defense. VA/DoD Clinical Practice Guidelines: management of posttraumatic stress disorder and acute stress reaction 2017. In: Department of Defense. 2017. A set of guidelines offered as a tool for clinicians for managing PTSD and acute stress within VA and DoD healthcare systems.

Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(2):617–27. https://doi.org/10.1001/archpsyc.62.6.617.CrossRefPubMedPubMedCentral

Miller MW, Fogler JM, Wolf EJ, Kaloupek DG, Keane TM. The internalizing and externalizing structure of psychiatric comorbidity in combat veterans. J Trauma Stress. 2008;21(1):58–65. https://doi.org/10.1002/jts.20303.CrossRefPubMedPubMedCentral

Brady KT, Back SE, Coffey SF. Substance abuse and posttraumatic stress disorder. Curr Dir Psychol Sci. 2004;13(5):206–9. https://doi.org/10.1111/j.0963-7214.2004.00309.x.CrossRef

Jacobsen LK, Southwick SM, Kosten TR. Substance use disorders in patients with posttraumatic stress disorder: a review of the literature. Am J Psychiatry. 2001;158(8):1184–90. https://doi.org/10.1176/appi.ajp.158.8.1184.CrossRefPubMed

Seal KH, Maguen S, Cohen B, Gima KS, Metzler TJ, Ren L, et al. VA mental health services utilization in Iraq and Afghanistan veterans in the first year of receiving new mental health diagnoses. J Trauma Stress. 2010;23(1):5–16. https://doi.org/10.1002/jts.20493.CrossRefPubMed

Gradus JL, Qin P, Lincoln AK, Miller M, Lawler E, Sorensen HT, et al. Posttraumatic stress disorder and completed suicide. Am J Epidemiol. 2010;171(6):721–7. https://doi.org/10.1093/aje/kwp456.CrossRefPubMed

10.

Foa EB, Hembree EA, Rothbaum BO. Prolonged exposure therapy for PTSD: emotional processing of traumatic experiences therapist guide. Treatments that work. New York: Oxford University Press; 2007.CrossRef

11.

Resick PA, Schnicke MK. Cognitive processing therapy for rape victims: a treatment manual. Sage; 1993.

12.

Hoge CW, Riviere LA, Wilk JE, Herrell RK, Weathers FW. The prevalence of post-traumatic stress disorder (PTSD) in US combat soldiers: a head-to-head comparison of DSM-5 versus DSM-IV-TR symptom criteria with the PTSD checklist. Lancet Psychiatry. 2014;1(4):269–77. https://doi.org/10.1016/s2215-0366(14)70235-4.CrossRefPubMed

13.

Stein DJ, McLaughlin KA, Koenen KC, Atwoli L, Friedman MJ, Hill ED, et al. DSM-5 and ICD-11 definitions of posttraumatic stress disorder: investigating “narrow” and “broad” approaches. Depress Anxiety. 2014;31(6):494–505. https://doi.org/10.1002/da.22279.CrossRefPubMedPubMedCentral

14.

O'Donnell ML, Alkemade N, Nickerson A, Creamer M, McFarlane AC, Silove D, et al. Impact of the diagnostic changes to post-traumatic stress disorder for DSM-5 and the proposed changes to ICD-11. Br J Psychiatry. 2014;205(3):230–5. https://doi.org/10.1192/bjp.bp.113.135285.CrossRefPubMed

15.

Resick PA, Monson CM, Chard KM. Cognitive processing therapy for PTSD: a comprehensive manual. Guilford Publications; 2016.

16.

Spoont MR, Murdoch M, Hodges J, Nugent S. Treatment receipt by veterans after a PTSD diagnosis in PTSD, mental health, or general medical clinics. Psychiatr Serv. 2010;61(1):58–63. https://doi.org/10.1176/appi.ps.61.1.58.CrossRefPubMed

17.

Kehle-Forbes SM, Meis LA, Spoont MR, Polusny MA. Treatment initiation and dropout from prolonged exposure and cognitive processing therapy in a VA outpatient clinic. Psychol Trauma. 2016;8(1):107–14. https://doi.org/10.1037/tra0000065.CrossRefPubMed

18.

Niles BL, Polizzi CP, Voelkel E, Weinstein ES, Smidt K, Fisher LM. Initiation, dropout, and outcome from evidence-based psychotherapies in a VA PTSD outpatient clinic. Psychol Serv. 2018;15(4):496–502. https://doi.org/10.1037/ser0000175.CrossRefPubMed

19.

Mott JM, Hundt NE, Sansgiry S, Mignogna J, Cully JA. Changes in psychotherapy utilization among veterans with depression, anxiety, and PTSD. Psychiatr Serv. 2014;65(1):106–12. https://doi.org/10.1176/appi.ps.201300056.CrossRefPubMed

20.

Shiner B, D’Avolio LW, Nguyen TM, Zayed MH, Young-Xu Y, Desai RA, et al. Measuring use of evidence based psychotherapy for posttraumatic stress disorder. Admin Pol Ment Health. 2013;40(4):311–8. https://doi.org/10.1007/s10488-012-0421-0.CrossRef

21.

Gutner CA, Suvak MK, Sloan DM, Resick PA. Does timing matter? Examining the impact of session timing on outcome. J Consult Clin Psychol. 2016;84(12):1108–15. https://doi.org/10.1037/ccp0000120.CrossRefPubMedPubMedCentral

22.

Gutner CA, Gallagher MW, Baker AS, Sloan DM, Resick PA. Time course of treatment dropout in cognitive–behavioral therapies for posttraumatic stress disorder. Psychol Trauma. 2016;8(1):115–21. https://doi.org/10.1037/tra0000062.CrossRefPubMed

23.

Lang AJ, Schnurr PP, Jain S, He F, Walser RD, Bolton E, et al. Randomized controlled trial of acceptance and commitment therapy for distress and impairment in OEF/OIF/OND veterans. Psychol Trauma. 2017;9(Suppl 1):74–84. https://doi.org/10.1037/tra0000127.CrossRefPubMed

24.

Imel ZE, Laska K, Jakupcak M, Simpson TL. Meta-analysis of dropout in treatments for posttraumatic stress disorder. J Consult Clin Psychol. 2013;81(3):394–404. https://doi.org/10.1037/a0031474.CrossRefPubMedPubMedCentral

25.

Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):629–40. https://doi.org/10.1001/archpsyc.62.6.629.CrossRefPubMed

26.

McHugh RK, Murray HW, Barlow DH. Balancing fidelity and adaptation in the dissemination of empirically-supported treatments: the promise of transdiagnostic interventions. Behav Res Ther. 2009;47(11):946–53. https://doi.org/10.1016/j.brat.2009.07.005.CrossRefPubMedPubMedCentral

27.

•• Sauer-Zavala S, Gutner CA, Farchione TJ, Boettcher HT, Bullis JR, Barlow DH. Current definitions of “transdiagnostic” in treatment development: a search for consensus. Behav Ther. 2017;48(1):128–38. https://doi.org/10.1016/j.beth.2016.09.004 This seminal paper discusses the term “transdiagnostic” as it is currently used in order to arrive a functional definition of the construct that can be used in future research. The authors discuss advantages and disadvantages of various treatment approaches that coincide with three different ways of using the term.

28.

Harvey A, Murray G, Chandler R, Soehner A. Sleep disturbance as transdiagnostic: consideration of neurobiological mechanisms. Clin Psychol Rev. 2011;31(2):225–35. https://doi.org/10.1016/j.cpr.2010.04.003.CrossRefPubMed

29.

Chorpita BF, Weisz JR. Modular approach to therapy for children with anxiety, depression, or conduct problems. Honolulu and Boston: University of Hawaii at Manoa and Judge Baker Children’s Center, Harvard Medical School; 2005.

30.

•• Murray LK, Hall BJ, Dorsey S, Ugueto AM, Puffer ES, Sim A, et al. An evaluation of a common elements treatment approach for youth in Somali refugee camps. Glob Ment Health. 2018;5:e16. https://doi.org/10.1017/gmh.2018.7 This study provides evidence for the use of a transdiagnostic approach among youth in Somali refugee camps, a community faced with high rates of trauma, high stigma around mental health care, and access to limited resources.

31.

Barlow DH, Farchione TJ, Fairholme CP, Ellard KK, Boisseau CL, Allen LB, et al. The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders: therapist guide. New York: Oxford University Press; 2011.

32.

•• Barlow DH, Farchione TJ, Bullis JR, Gallagher MW, Murray-Latin H, Sauer-Zavala S, et al. The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders compared with diagnosis-specific protocols for anxiety disorders: a randomized clinical trial. JAMA Psychiatry. 2017;74(9):875–84. https://doi.org/10.1001/jamapsychiatry.2017.2164 This non-inferiority randomized clinical trial demonstrated that the Unified Protocol was at least as efficacious as single disorder protocols in the treatment of emotional disorders.

33.

Norton PJ, Hope DA. Preliminary evaluation of a broad-spectrum cognitive-behavioral group therapy for anxiety. J Behav Ther Exp Psychiatry. 2005;36(2):79–97. https://doi.org/10.1016/j.jbtep.2004.07.002.CrossRefPubMed

34.

Weiss WM, Murray LK, Zangana GAS, Mahmooth Z, Kaysen D, Dorsey S, et al. Community-based mental health treatments for survivors of torture and militant attacks in southern Iraq: a randomized control trial. BMC Psychiatry. 2015;15(1):1–16. https://doi.org/10.1186/s12888-015-0622-7.CrossRef

35.

•• Chorpita BF, Daleiden EL, Park AL, Ward AM, Levy MC, Cromley T, et al. Child STEPs in California: a cluster randomized effectiveness trial comparing modular treatment with community implemented treatment for youth with anxiety, depression, conduct problems, or traumatic stress. J Consult Clin Psychol. 2017;85(1):13–25. https://doi.org/10.1037/ccp0000133 This effectiveness trial showed that a transdiagnostic approach, MATCH, delivered in a modular format for youth outperformed a program for community integration of multiple evidence based practices on measures of clinical and functional outcomes.

36.

• Varkovitzky RL, Sherrill AM, Reger GM. Effectiveness of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders among veterans with posttraumatic stress disorder: a pilot study. Behav Modif. 2018;42(2):210–30. https://doi.org/10.1177/0145445517724539 This pilot study is the first to examine effectiveness of the Unified Protocol with veterans diagnosed with PTSD delivered in a group format in routine care.

37.

•• Castro-Camacho L, Moreno JD, Naismith I. Contextual adaptation of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in victims of the armed conflict in Colombia: a case study. Cogn Behav Pract. 2018;26:366–80. https://doi.org/10.1016/j.cbpra.2018.09.002. This study offers an example of a cultural adaptation of the Unified Protocol in a community with high rates of trauma exposure.CrossRef

38.

•• Gutner CA, Galovski T, Bovin MJ, Schnurr PP. Emergence of transdiagnostic treatments for PTSD and posttraumatic distress. Curr Psychiatry Rep. 2016;18(10):95. https://doi.org/10.1007/s11920-016-0734-x This paper is one of the first to highlight the applicability of transdiagnostic treatments for PTSD and trauma-related distress.

39.

• Gallagher MW. Transdiagnostic mechanisms of change and cognitive-behavioral treatments for PTSD. Curr Opin Psychol. 2017;14:90–5. https://doi.org/10.1016/j.copsyc.2016.12.002 This article puts forth a conceptual framework and preliminary support for the use of transdiagnostic approaches for PTSD.

40.

• Mahmooth Z, Weiss WM, GAS Z, Bolton P. Study participant reported outcomes of mental health interventions: results from a randomized controlled trial among survivors of systematic violence in southern Iraq. Glob Ment Health. 2018;5:e19. https://doi.org/10.1017/gmh.2018.11 This randomized clinical trial compares a transdiagnostic approach (CETA) to an evidence-based psychotherapy, Cognitive Processing Therapy, in a trauma-exposed sample in Iraq. Results showed that participants in the CETA condition reported more positive changes in follow-up interviews compared to CPT; however, effect sizes were small and well validated assessment measures were not used.

41.

Erickson DH, Janeck AS, Tallman K. Transdiagnostic group CBT for anxiety: clinical experience and practical advice. J Cogn Psychother. 2009;23:34–43. https://doi.org/10.1891/0889-8391.23.1.34.CrossRef

42.

•• Murray LK, Haroz EE, Doty SB, Singh NS, Bogdanov S, Bass J, et al. Testing the effectiveness and implementation of a brief version of the Common Elements Treatment Approach (CETA) in Ukraine: a study protocol for a randomized controlled trial. Trials. 2018;19(1):418. https://doi.org/10.1186/s13063-018-2752-y This protocol paper outlines the study design for a study examining the effectiveness and implementation of a transdiagnostic intervention, CETA, compared to a brief 5-session version, when delivered by lay persons in Ukraine. Results gathered will further the knowledge of enhanced flexibility of these interventions.

43.

•• Bonilla-Escobar FJ, Fandiño-Losada A, Martínez-Buitrago DM, Santaella-Tenorio J, Tobón-García D, Muñoz-Morales EJ, et al. A randomized controlled trial of a transdiagnostic cognitive-behavioral intervention for Afro-descendants’ survivors of systemic violence in Colombia. PLoS One. 2018;13(12):e0208483. https://doi.org/10.1371/journal.pone.0208483 This RCT study found empirical support for the use of transdiagnostic CBT, CETA, in Colombia.

44.

Chorpita BF, Daleiden EL. Mapping evidence-based treatments for children and adolescents: application of the distillation and matching model to 615 treatments from 322 randomized trials. J Consult Clin Psychol. 2009;77(3):566–79. https://doi.org/10.1037/a0014565.CrossRefPubMed

45.

•• Peterson RA, Darnell D, Berliner L, Dorsey S, Murray L, Monroe-DeVita M, et al. Implementing transdiagnostic cognitive behavioral psychotherapy in adult public behavioral health: a pilot evaluation of the feasibility of the Common Elements Treatment Approach (CETA). J Behav Health Serv Res. 2018;46:249–66. https://doi.org/10.1007/s11414-018-9631-x. Whereas much research on CETA has occurred globally, this study offers support for the feasibility of the CETA with an adult US population.CrossRef

46.

Foa EB, Johnson KM, Feeny NC, Treadwell KRH. The Child PTSD Symptom Scale: a preliminary examination of its psychometric properties. J Clin Child Adolesc Psychol. 2001;30(3):376–84. https://doi.org/10.1207/S15374424JCCP3003_9.CrossRef

47.

Foa EB. The Child PTSD Symptom Scale (CPSS). www.midss.org. 2001.

48.

Gratz KL, Roemer L. Multidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the difficulties in emotion regulation scale. J Psychopathol Behav Assess. 2004;26(1):41–54. https://doi.org/10.1023/b:Joba.0000007455.08539.94.CrossRef

49.

Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann. 2002;32:509–15. https://doi.org/10.3928/0048-5713-20020901-06.CrossRef

50.

Weathers FW, Litz BT, Keane TM, Palmieri PA, Marx BP, Schnurr PP. The PTSD checklist for DSM-5 (PCL-5). Scale available from the National Center for PTSD. 2013.

51.

Goetter EM, Bui E, Ojserkis RA, Zakarian RJ, Brendel RW, Simon NM. A systematic review of dropout from psychotherapy for posttraumatic stress disorder among Iraq and Afghanistan combat veterans. J Trauma Stress. 2015;28(5):401–9. https://doi.org/10.1002/jts.22038.CrossRefPubMed

52.

Cook JM, Schnurr PP, Foa EB. Bridging the gap between posttraumatic stress disorder research and clinical practice: the example of exposure therapy. Psychotherapy. 2004;41(4):374–87. https://doi.org/10.1037/0033-3204.41.4.374.CrossRef

53.

Gallo KP, Barlow DH. Factors involved in clinician adoption and nonadoption of evidence-based interventions in mental health. Clin Psychol Sci Pract. 2012;19(1):93–106. https://doi.org/10.1111/j.1468-2850.2012.01276.x.CrossRef

54.

von Ranson KM, Robinson KE. Who is providing what type of psychotherapy to eating disorder clients? A survey. Int J Eat Disord. 2006;39(1):27–34. https://doi.org/10.1002/eat.20201.CrossRef

55.

Gutner CA, Sloan DM, Wiltsey Stirman S. Effectiveness of a unified transdiagnostic treatment in routine clinical care. VA Boston Healthcare System Trustees of Boston University, BUMC; 2014.

56.

Rosellini AJ, Brown TA. The Multidimensional Emotional Disorder Inventory (MEDI): assessing transdiagnostic dimensions to validate a profile approach to emotional disorder classification. Psychol Assess. 2019;31(1):59–72. https://doi.org/10.1037/pas0000649.CrossRefPubMed

57.

Rosellini AJ, Boettcher H, Brown TA, Barlow DH. A transdiagnostic temperament-phenotype profile approach to emotional disorder classification: an update. J Exp Psychopathol. 2015;a2(1):110–28. https://doi.org/10.5127/pr.036014.CrossRefPubMedPubMedCentral

58.

Dopp AR, Mundey P, Beasley LO, Silovsky JF, Eisenberg D. Mixed-method approaches to strengthen economic evaluations in implementation research. Implement Sci. 2019;14(1):2. https://doi.org/10.1186/s13012-018-0850-6.CrossRefPubMedPubMedCentral

59.

• Kazdin AE. Addressing the treatment gap: a key challenge for extending evidence-based psychosocial interventions. Behav Res Ther. 2017;88:7–18. https://doi.org/10.1016/j.brat.2016.06.004 This article speaks to the current mental health challenges faced around the globe and how to start addressing the treatment gap.

60.

• Murray LK, Haroz EE, Pullmann MD, Dorsey S, Kane J, Augustinavicius J, et al. Under the hood: lay counsellor element use in a modular multi-problem transdiagnostic intervention in lower resource countries. Cogn Behav Ther. 2019;12:e6. https://doi.org/10.1017/S1754470X18000144 The study was conducted with lay counselors in Iraq and Thailand who, under supervision, were found to demonstrate fidelity to CETA and to provide flexibility in the treatment without extending duration. This study shows promise for the use of modular approaches by lay persons in low resourced settings.

Titel: Dealing with Complexity and Comorbidity: Opportunity for Transdiagnostic Treatment for PTSD
verfasst von: Cassidy A. Gutner, PhD
Candice Presseau, PhD
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Current Treatment Options in Psychiatry / Ausgabe 2/2019
Elektronische ISSN: 2196-3061
DOI: https://doi.org/10.1007/s40501-019-00170-2

Adjusting the Timeframe of Evidence-Based Therapies for PTSD-Massed Treatments

PTSD (S Creech and L Sippel, Section Editors)

Current State of the Problem: Opioid Overdose Rates and Deaths

Substance Use Disorders (FG Moeller, Section Editor)

Augmenting Treatment for Posttraumatic Stress Disorder and Co-Occurring Conditions with Oxytocin

PTSD (S Creech and L Sippel, Section Editors)

Augmenting the Treatment of PTSD with Ketamine—a Review

PTSD (S Creech and L Sippel, Section Editors)

New-generation Antipsychotics and Cardiovascular Risk

Schizophrenia and Other Psychotic Disorders (J Csernansky, Section Editor)

Brief Novel Therapies for PTSD: Written Exposure Therapy

PTSD (S Creech and L Sippel, Section Editors)

Neu im Fachgebiet Psychiatrie

Medikamente verändern wohl Nährstoffzusammensetzung der Muttermilch

Medikamente in Schwangerschaft und Stillzeit
Nachrichten

Einige Medikamente wie selektive Serotonin-Wiederaufnahmehemmer können offenbar die Makronährstoffzusammensetzung der Muttermilch verändern. Das birgt möglicherweise gesundheitliche Risiken für manche gestillte Kinder.

Psychologische Interventionen können Depressionen oft verhindern

16.12.2024
Depressive Störungen
Nachrichten

Gespräche, Telefonate, internetbasierte Verfahren: Mit solchen Methoden lässt sich der Beginn einer Depression bei gefährdeten Personen oft vermeiden. Sie funktionieren vor allem dann, wenn die Betroffenen deutliche Symptome aufweisen und noch keine Psychotherapie hatten.

Die beste Medizin gegen Altersdepression: Laufen, Lernen, Lachen, Lieben

13.12.2024
Altersdepression
Nachrichten

Depressionen im Alter haben vielfältige Ursachen und verlaufen anders als bei jungen Menschen. Ohne einen multimodalen Ansatz kommt man oft nicht weit: Neben Medikamenten und Psychotherapien ist die physische, kognitive und soziale Aktivierung entscheidend.

Wir sozio-emotionalen Blobs

13.12.2024
DGPPN 2024
Nachrichten

Entscheidungen sollten rational erfolgen – in der Politik wie im Leben. So wünschen wir uns das. Letztlich werden sie aber von Emotionen bestimmt. Wer das nicht versteht und anerkennt, wird kaum Wege aus Krisen finden. Die Neurowissenschaftlerin Maren Urner fordert daher eine „Reifeprüfung“ zur Krisenbewältigung.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Dealing with Complexity and Comorbidity: Opportunity for Transdiagnostic Treatment for PTSD